Sherrington Robin - Net Worth and Insider Trading
Sherrington Robin Net Worth
The estimated net worth of Sherrington Robin is at least $353,640 dollars as of 2024-11-05. Sherrington Robin is the EVP, Strategy & Innovation of Xenon Pharmaceuticals Inc and owns about 8,398 shares of Xenon Pharmaceuticals Inc (XENE) stock worth over $353,640. Details can be seen in Sherrington Robin's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Sherrington Robin has not made any transactions after 2024-03-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Sherrington Robin
Sherrington Robin Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Sherrington Robin owns 1 companies in total, including Xenon Pharmaceuticals Inc (XENE) .
Click here to see the complete history of Sherrington Robin’s form 4 insider trades.
Insider Ownership Summary of Sherrington Robin
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| XENE | Xenon Pharmaceuticals Inc | 2024-03-07 | SVP Bus. & Corp. Development |
Sherrington Robin Latest Holdings Summary
Sherrington Robin currently owns a total of 1 stock. Sherrington Robin owns 8,398 shares of Xenon Pharmaceuticals Inc (XENE) as of March 7, 2024, with a value of $353,640.
Latest Holdings of Sherrington Robin
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| XENE | Xenon Pharmaceuticals Inc | 2024-03-07 | 8,398 | 42.11 | 353,640 |
Holding Weightings of Sherrington Robin
Sherrington Robin Form 4 Trading Tracker
According to the SEC Form 4 filings, Sherrington Robin has made a total of 3 transactions in Xenon Pharmaceuticals Inc (XENE) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Xenon Pharmaceuticals Inc is the sale of 7,137 shares on March 7, 2024, which brought Sherrington Robin around $330,300.
Insider Trading History of Sherrington Robin
- 1
Sherrington Robin Trading Performance
Sherrington Robin Ownership Network
Ownership Network List of Sherrington Robin
Ownership Network Relation of Sherrington Robin
Sherrington Robin Owned Company Details
What does Xenon Pharmaceuticals Inc do?
Who are the key executives at Xenon Pharmaceuticals Inc?
Sherrington Robin is the SVP Bus. & Corp. Development of Xenon Pharmaceuticals Inc. Other key executives at Xenon Pharmaceuticals Inc include director & PRESIDENT & CEO Ian Mortimer , Chief Medical Officer Christopher John Kenney , and Chief Legal Officer Andrea Difabio .
Xenon Pharmaceuticals Inc (XENE) Insider Trades Summary
Over the past 18 months, Sherrington Robin made 1 insider transaction in Xenon Pharmaceuticals Inc (XENE) with a net sale of 7,137. Other recent insider transactions involving Xenon Pharmaceuticals Inc (XENE) include a net sale of 26,576 shares made by Gary Patou , a net sale of 131,245 shares made by Simon N. Pimstone , and a net sale of 31,655 shares made by Ian Mortimer .
In summary, during the past 3 months, insiders sold 0 shares of Xenon Pharmaceuticals Inc (XENE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 236,705 shares of Xenon Pharmaceuticals Inc (XENE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 236,705 shares.
Xenon Pharmaceuticals Inc (XENE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Xenon Pharmaceuticals Inc Insider Transactions
Sherrington Robin Mailing Address
Above is the net worth, insider trading, and ownership report for Sherrington Robin. You might contact Sherrington Robin via mailing address: C/o Xenon Pharmaceuticals Inc., 200 - 3650 Gilmore Way, Burnaby A1 V5g4w8.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
